Having an appropriate strategy forms a critical component of success, and for Dr. Clay Siegall, the great feats of success that he is currently associated with could not have been achieved were it not for his clear understanding of the deficiency that existed in the field of medicine. In addition to that, his previous experience put him in a position to develop the desire for bringing more advanced solutions that had never been tried out ever before in the process of curing cancer.
For the longest time, oncologists used to employ chemotherapy in trying to cure the deadly disease. While the method was efficient and it helped to prolong the life of many people in the society, Dr. Clay Siegall felt that more focus needed to be placed on the invention of a targeted therapy which was not actually associated with much pain like chemotherapy.
Dr. Clay Siegall understood very well the difficulty that his father had to go through in the process of chemotherapy and it was his greatest desire to ensure that a lesser number of people who had cancer needed to go through the same pain in the course of undertaking chemotherapy sessions. Dr. Clay Siegall is attributed with the development of targeted methods of treating cancer through the use of ADC’s in his Seattle Genetics facility.
Dr. Clay Siegall is well learned since he has a degree in zoology from the University of Maryland and a PhD in genetics from Oxford University. His previous work experience in other organizations such as Bristol-Myers Pharmaceutical Research Institute helped him to have a better understanding of what he was supposed to set up when he decided to venture into the production of cancer medication.
In 1998, he established Seattle Genetics, and he has managed the company both as a scientist and as a business person. For instance, he led the Company to raise capital from different private and public businesses and the finance has considerably helped to advance further research in the organization.
The great research undertakings that Dr. Clay Siegall has led his company to achieve have made him be awarded numerous awards in recognition of the efforts that he puts into the development of better medication. Dr. Clay Siegall holds more than 15 patents and 70 publications in various fields of medicine.